Cytotoxic T-lymphocyte antigen-4 (CTLA4) is an immune checkpoint protein expressed on regulatory T (Treg) cells and activated T cells that downregulate T cell activation and suppress anti-tumor immune responses in response to T cell receptor engagement [107,108,109]. Here, CTLA4 is linked to neoplasm.